Sex steroids in androgen-secreting adrenocortical tumors: Clinical and hormonal features in comparison with non-tumoral causes of androgen excess

European Journal of Endocrinology

Volumn 159, Issue 5, 2008, Pages 641-647

  d'Alva, Catarina B ^a   Abiven Lepage, Gwenaelle ^a,b   Viallon, Vivian ^a,b   Groussin, Lionel ^a,b,c   Dugue, Marie Annick ^a,b   Bertagna, Xaiver ^a,b,c,d   Bertherat, Jerôme ^a,b,c  

^a Institut Cochin   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT COCHIN   (France)

^d Institut Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE; TESTOSTERONE;

ACNE; ADOLESCENT; ADRENAL CORTEX TUMOR; ADULT; AGED; AMENORRHEA; ANDROGEN BLOOD LEVEL; ANDROGEN RELEASE; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLITROPIN BLOOD LEVEL; HIRSUTISM; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; OLIGOMENORRHEA; PREVALENCE; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; ANDROGENS; ANDROSTENEDIONE; DEHYDROEPIANDROSTERONE SULFATE; ESTROGENS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYDROCORTISONE; LUTEINIZING HORMONE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TESTOSTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 56749158208     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0324     Document Type: Article

References (34)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR & Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Journal of Clinical Endocrinology and Metabolism 1998 83 3078-3082.
2. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S & Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism 2000 85 2434-2438.
3. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K & Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. Journal of Clinical Endocrinology and Metabolism 2004 89 453-462.
4. Carmina E, Rosato F, Janni A, Rizzo M & Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 2006 91 2-6.
5. Libe R, Fratticci A & Bertherat J. Adrenocortical cancer: pathophysiology and clinical management. Endocrine-Related Cancer 2007 14 13-28.
6. Management of hirsutism. Drug and Therapeutics Bulletin 1989 27 49-51.
7. Rosenfield RL. Clinical practice. Hirsutism. New England Journal of Medicine 2005 353 2578-2588.
8. Kaltsas GA, Isidori AM, Kola BP, Skelly RH, Chew SL, Jenkins PJ, Monson JF, Grossman AB & Besser GM. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. Journal of Clinical Endocrinology and Metabolism 2003 88 2634-2643.
9. Rosenfield RL, Cohen RM & Talerman A. Lipid cell tumor of the ovary in reference to adult-onset congenital adrenal hyperplasia and polycystic ovary syndrome. A case report. Journal of Reproductive Medicine 1987 32 363-369.
10. Waggoner W, Boots LR & Azziz R. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Gynecological Endocrinology 1999 13 394-400.
11. O'Driscoll JB, Mamtora H, Higginson J, Pollock A, Kane J & Anderson DC. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clinical Endocrinology 1994 41 231-236.
12. Derksen J, Nagesser SK, Meinders AE, Haak HR & van de Velde CJ. Identification of virilizing adrenal tumors in hirsute women. New England Journal of Medicine 1994 331 968-973.
13. Tissier F, Louvel A, Grabar S, Hagnere AM, Bertherat J, Vacher-Lavenu MC, Dousset B, Chapuis Y, Bertagna X & Gicquel C. Cyclin E correlates with malignancy and adverse prognosis in adreno-cortical tumors. European Journal of Endocrinology 2004 150 809-817.
14. Tissier F, Cavard C, Groussin L, Perlemoine K, Furney G, Hagnere AM, Rene-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C & Bertherat J. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Research 2005 65 7622-7627.
15. Libe R, Groussin L, Tissier F, Elie C, Rene-Corail F, Fratticci A, Jullian E, Beck-Peccoz P, Bertagna X, Gicquel C & Bertherat J. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity. Clinical Cancer Research 2007 13 844-850.
16. Speroff L. Dysfunctional uterine bleeding. In Clinical Gynecologic Endocrinology and Infertility, edn 7, Eds MA Fritz & L Speroff, Philadelphia: Lippincott Williams and Wilkins, Philadelphia, USA, 2005.
17. Fauser BCJM for the Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 19 41-47.
18. Carmina E, Chu MC, Longo RA, Rini GB & Lobo RA. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. Journal of Clinical Endocrinology and Metabolism 2005 90 2545-2549.
19. Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna X, Luton JP & Bertherat J. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. Journal of Clinical Endocrinology and Metabolism 2000 85 3779-3785.
20. Luton JP, Martinez M, Coste J & Bertherat J. Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center. European Journal of Endocrinology 2000 143 111-117.
21. Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X & Bertherat J. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. European Journal of Endocrinology 2004 150 763-771.
22. Youden WJ. Index for rating diagnostic tests. Cancer 1950 3 32-35.
23. Latronico AC & Chrousos GP. Extensive personal experience: adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 1997 82 1317-1324.
24. Kloos RT, Gross MD, Francis IR, Korobkin M & Shapiro B. Incidentally discovered adrenal masses. Endocrine Reviews 1995 16 460-484.
25. Bertherat J. Mosnier-Pudar H & Bertagna X. Adrenal incidentalomas. Current Opinion in Oncology 2002 14 58-63.
26. Libe R & Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. European Journal of Endocrinology 2005 153 477-487.
27. Doppman JL. Problems in endocrinologic imaging. Endocrinology and Metabolism Clinics of North America 1997 26 973-991.
28. Bornstein SR, Stratakis CA & Chrousos GP. Adrenocortical tumors: recent advances in basic concepts and clinical management. Annals of Internal Medicine 1999 130 759-771.
29. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G & Klibanski A. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. Journal of Clinical Endocrinology and Metabolism 2004 89 525-533.
30. Mendonca BB, Lucon AM, Menezes CA, Saldanha LB, Latronico AC, Zerbini C, Madureira G, Domenice S, Albergaria MA & Camargo MH. Clinical, hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood. Journal of Urology 1995 154 2004-2009.
31. Bertherat J, Groussin L & Bertagna X. Mechanisms of disease: adrenocortical tumors - molecular advances and clinical perspectives. Nature Clinical Practice. Endocrinology and Metabolism 2006 2 632-641.
32. Lado-Abeal J, Rodriguez-Arnao J, Newell-Price JD, Perry LA, Grossman AB, Besser GM & Trainer PJ. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. Journal of Clinical Endocrinology and Metabolism 1998 83 3083-3088.
33. Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M, Plouin PF, Luton JP & Le Bouc Y. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Research 2001 61 6762-6767.
34. Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X & Bertherat J. Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. Journal of Clinical Endocrinology and Metabolism 2006 91 2650-2655.